correspond
author
da
graham
see
front
matter
elsevi
scienc
bv
right
reserv
pii
influenc
igmrf
igmspecif
indirect
elisa
igm
respons
three
panel
sera
gener
infect
reinfect
calv
bovin
respiratori
syncyti
viru
brsv
measur
indirect
elisa
ielisa
effect
deplet
serum
igg
pretreat
protein
g
agaros
pga
evalu
follow
primari
infect
weak
igm
respons
detect
untreat
sera
calv
matern
deriv
antibodi
mda
magnitud
durat
specif
igm
respons
calv
increas
pretreat
pga
addit
fourth
infect
calf
test
gave
singl
posit
igm
result
follow
pga
treatment
transient
persist
igm
respons
abolish
pretreat
sera
pga
detect
calv
follow
reinfect
consid
fals
posit
result
consist
influenc
igm
rheumatoid
factor
igmrf
one
calv
two
addit
calv
show
transient
increas
igm
resist
pga
treatment
consid
repres
specif
igm
respons
reinfect
result
indic
abil
pga
treatment
elimin
fals
posit
fals
neg
result
emphasis
necess
control
veterinari
immunolog
immunopatholog
serodiagnosi
viral
infect
use
igmrestrict
assay
offer
possibl
obtain
rapid
result
compar
test
seroconvers
sinc
diagnosi
made
without
wait
collect
convalesc
serum
sampl
meurman
addit
assay
shown
sensit
test
seroconvers
face
matern
deriv
antibodi
mda
kimman
et
al
westenbrink
kimman
graham
et
al
immunoassay
protocol
igm
detect
typic
use
either
indirect
antibodi
class
captur
elisa
accelisa
indirect
elisa
ielisa
specif
igm
must
compet
specif
iga
andor
igg
bind
antigen
solid
phase
interisotyp
competit
accelisa
total
serum
igm
proport
antigenspecif
captur
polyclon
monoclon
antiigm
antibodi
solid
phase
assay
therefor
subject
intraisotyp
competit
interand
intraisotyp
competit
may
reduc
sensit
assay
meurman
addit
rheumatoid
factor
igm
isotyp
igmrf
may
gener
fals
posit
igm
signal
especi
ielisa
protocol
follow
requir
presenc
antigenspecif
igg
igmrf
well
document
relat
human
pathogen
salonen
et
al
yolken
leister
tuokko
igmrf
autoantibodi
specif
cg
interfac
homolog
heterolog
igg
waron
et
al
sasso
et
al
presenc
igmrf
bovin
sera
demonstr
ungar
graham
et
al
retest
posit
sera
follow
pretreat
hyperimmun
antiserum
bovin
igg
fc
ungarwaron
abraham
demonstr
fals
posit
rate
field
sera
test
ielisa
bovin
herp
igm
subsequ
use
novel
method
deplet
igg
bovin
sera
base
treatment
protein
g
bound
crosslink
agaros
matrix
pga
graham
et
al
detect
fals
posit
rate
field
sera
test
ielisa
bovin
respiratori
syncyti
virusspecif
igm
brsvigm
gener
fals
posit
result
continu
obstacl
wider
use
igmrestrict
assay
veterinari
serodiagnosi
brsvigm
result
obtain
ielisa
use
test
sera
gener
experiment
infect
seroneg
calv
describ
previous
graham
et
al
follow
aim
work
describ
present
paper
follow
determin
abil
ielisa
detect
brsvigm
respons
follow
experiment
infect
calv
presenc
mda
follow
experiment
reinfect
compar
seroconvers
result
determin
whether
develop
fals
posit
igm
signal
could
observ
one
calv
infect
reinfect
examin
effect
pga
treatment
sera
magnitud
durat
igm
respons
compar
result
describ
previous
similar
set
sera
test
accelisa
kimman
et
al
b
three
panel
sera
gener
experiment
infect
reinfect
calv
six
convent
rear
colostrum
supplement
friesian
x
calv
bought
week
age
infectedmockinfect
seven
week
later
hous
isol
facil
throughout
experiment
period
calv
panel
test
blood
sampl
collect
serial
purchas
infect
indic
declin
level
brsvspecif
igg
brsvigg
consist
antibodi
matern
deriv
two
calv
lowest
level
brsvigg
serv
control
hous
separ
prior
inocul
mockinfect
foetal
bovin
lung
cell
fbl
frozen
thaw
calf
receiv
ml
intratrach
ml
nostril
way
remain
four
calv
inocul
crude
lysat
fbl
cell
infect
swedish
brsv
isol
sva
frozen
thaw
viral
cytopath
effect
observ
clot
blood
sampl
collect
calf
day
post
infect
dpi
fiftyfour
day
initi
infect
six
calv
reinocul
bled
day
later
panel
sera
viral
titr
inocula
use
infect
reinfect
tcid
ml
respect
panel
sera
gener
reinfect
four
calv
swedish
brsv
isol
sva
tcid
ml
month
age
follow
protocol
serial
serum
sampl
collect
day
post
reinfect
dpr
calv
initi
infect
isol
day
earlier
time
seroneg
elvand
et
al
sera
held
prior
test
brsvigm
detect
ielisa
previous
describ
graham
et
al
sera
test
without
prior
deplet
igg
use
suspens
pga
phosphat
buffer
salin
ph
contain
tween
graham
et
al
result
serum
express
percentag
posit
refer
serum
includ
plate
sp
sera
sp
valu
consid
given
posit
brsvigm
result
graham
et
al
chang
brsvigg
level
follow
infectionreinfect
detect
use
commerci
avail
ielisa
rsvab
svanova
biotech
uppsala
sera
test
dilut
accord
manufactur
recommend
deem
posit
correct
optic
densiti
cod
addit
sera
collect
dpi
panel
dpr
panel
dpr
panel
test
evid
seroconvers
singledilut
elisa
previous
describ
graham
et
al
sera
test
dilut
increas
sp
acut
convalesc
sampl
indic
fourfold
greater
increas
titr
sera
test
brsvigm
without
pretreat
pga
calv
show
transient
respons
fig
peak
sp
valu
na
respect
tabl
brsvigm
detect
calf
dpi
calf
dpi
brsvigm
detect
calf
day
post
infect
respons
detect
two
control
calv
sera
test
pga
treatment
day
peak
brsvigm
respons
observ
three
calv
unchang
increas
magnitud
durat
brsvigm
respons
observ
fig
peak
sp
valu
increas
calv
respect
tabl
brsvigm
detect
calf
dpi
calf
dpi
calf
dpi
addit
calf
gave
singl
posit
brsvigm
result
day
post
infect
sera
pretreat
pga
none
six
calv
show
brsvigg
respons
inocul
suffici
indic
seroconvers
level
remain
rel
stabl
show
overal
declin
sampl
period
respons
reinocul
detect
control
calv
either
without
prior
treatment
pga
fig
remain
four
calv
brsvigm
neg
reinfect
irrespect
prior
treatment
pga
absenc
pga
treatment
plot
calv
similar
consist
three
compon
firstli
sp
valu
increas
becam
posit
decreas
final
increas
sharpli
howev
respons
gener
two
calv
differ
pga
treatment
calf
demonstr
brsvigm
respons
reinfect
peak
nine
day
reinfect
thereaft
sp
valu
fell
positiveneg
threshold
pnt
remain
contrast
brsvigm
respons
calf
complet
abolish
calf
also
appear
give
brsvigm
respons
reinfect
sp
valu
untreat
sera
becom
posit
rise
peak
decreas
neg
valu
howev
plot
calf
follow
pga
treatment
sera
similar
shape
reduc
magnitud
sera
becam
neg
two
plot
calf
similar
shape
magnitud
rise
peak
valu
day
reinfect
follow
steadi
decreas
sp
valu
except
pgatreat
sera
collect
day
reinfect
neg
follow
reinfect
brsvigg
level
calv
rose
sharpli
initi
plateau
declin
toward
end
sampl
period
fig
seroconvers
detect
calv
brsvigg
level
calv
continu
declin
mock
reinfect
consist
antibodi
matern
deriv
sera
test
without
prior
treatment
pga
calv
neg
brsvigm
time
reinfect
throughout
follow
period
fig
follow
pga
treatment
howev
three
calv
test
posit
time
reinfect
vari
period
thereaft
brsvigm
sp
valu
calv
show
downward
trend
respect
becom
neg
day
reinfect
contrast
calf
show
transient
low
level
igm
respons
reinfect
sp
valu
rise
reinfect
five
day
later
becom
neg
four
day
fig
tabl
calf
show
differ
pattern
test
posit
reinfect
subsequ
upward
trend
brsvigm
sp
valu
test
perform
without
prior
treatment
sera
pga
give
maximum
valu
end
sampl
period
dpr
howev
pga
treatment
result
opposit
downward
trend
becom
neg
five
day
reinfect
brsvigg
level
stabl
rose
slowli
follow
reinfect
none
calv
seroconvert
suppress
effect
mda
humor
respons
brsv
infect
well
recognis
igmspecif
respons
shown
resist
suppress
mda
igg
respons
kimman
et
al
b
differenti
suppress
evid
igmand
iggspecif
respons
primari
brsv
infect
shown
four
infect
panel
calv
gener
invers
relationship
evid
brsvigg
level
time
infect
subsequ
igm
respons
consist
find
kimman
et
al
none
four
calv
seroconvert
follow
infect
defin
fourfold
greater
increas
specif
igg
level
igm
profil
two
three
calv
show
respons
sera
test
without
pretreat
pga
short
durat
low
intens
tabl
fig
find
contrast
previous
describ
result
obtain
ielisa
absenc
mda
four
calv
use
gener
panel
sera
initi
infect
brsv
seroneg
four
seroconvert
test
posit
igm
igm
respons
detect
day
peak
sp
valu
rang
elvand
et
al
graham
et
al
protein
g
immunoglobulinbind
bacteri
cell
wall
protein
unlik
protein
bind
bovin
igg
igg
bjo
kronval
kerstro
et
al
pretreat
bovin
sera
pga
prior
test
brsvigm
ielisa
novel
procedur
previous
shown
effect
deplet
serum
igg
graham
et
al
remov
competit
two
isotyp
bind
site
solid
phase
increas
magnitud
brsvigm
respons
sera
contain
brsvigg
igm
graham
et
al
result
report
panel
sera
confirm
extend
previou
result
overal
shape
igm
profil
calv
similar
without
pga
treatment
sera
howev
mark
increas
magnitud
igm
sp
valu
sera
appar
follow
treatment
proport
sera
result
chang
statu
neg
posit
concomit
increas
period
calf
test
posit
addit
calf
brsvigm
neg
throughout
sampl
period
sera
test
without
pga
treatment
gave
singl
low
posit
igm
result
dpi
follow
pga
treatment
similar
effect
evid
start
sampl
period
panel
sera
calv
brsvigm
neg
test
without
pga
treatment
test
posit
valu
rang
treat
pga
igm
consid
repres
tail
end
respons
initi
infect
day
previous
support
steadi
declin
signal
less
pnt
valu
calv
igmrfinduc
fals
posit
signal
aris
ielisa
antiigm
label
react
igmrf
bound
specif
igg
attach
solid
phase
antigen
shown
depend
level
specif
igg
igmrf
level
champsaur
et
al
therefor
deplet
serum
igg
one
practic
method
elimin
fals
posit
igm
result
although
level
fals
posit
igm
signal
greatli
reduc
accelisa
may
still
occur
control
antigen
includ
kryger
et
al
yolken
leister
find
follow
reinfect
sera
calv
panel
panel
test
brsvigm
posit
without
pga
treatment
becam
neg
follow
deplet
serum
igg
consist
fals
posit
result
due
interact
igmrf
specif
igg
sera
champsaur
et
al
ungarwaron
abraham
case
calf
fals
posit
igm
signal
transient
wherea
calv
show
steadi
increas
signal
strength
toward
end
sampl
period
fig
pnt
valu
determin
previous
repres
mean
plu
two
standard
deviat
sp
valu
record
healthi
calv
previou
histori
respiratori
diseas
graham
et
al
observ
follow
pga
treatment
calf
panel
show
transient
igm
respons
fail
reach
valu
may
indic
pnt
valu
high
dpr
igm
valu
calf
similar
pga
treatment
transient
rise
peak
valu
excess
pnt
valu
indic
develop
fals
posit
igm
respons
calf
preced
initi
specif
igm
signal
first
time
sequenti
develop
fals
posit
igm
signal
ielisa
system
demonstr
way
result
suggest
fals
posit
signal
associ
reinfect
rather
primari
infect
possibl
due
higher
level
specif
igg
associ
latter
gener
fals
posit
result
attribut
igmrf
may
help
explain
previou
report
prolong
igm
respons
brsv
bovin
coronaviru
detect
ielisa
stewart
gershwin
heckert
et
al
brsvigm
result
gener
follow
pga
treatment
consid
specif
three
eight
calv
panel
combin
show
weak
transient
increas
brsvigm
level
follow
reinfect
three
eight
calv
seroconvert
comparison
kimman
et
al
detect
igm
respons
reinfect
accelisathi
may
indic
sensit
ielisa
exce
accelisa
possibl
reflect
differ
rel
signific
interisotyp
competit
former
intraisotyp
competit
latter
whilst
intraisotyp
competit
may
produc
fals
neg
result
van
zaan
ijzerman
deplet
serum
igg
pga
demonstr
studi
markedli
reduc
impact
interisotyp
competit
conclus
result
obtain
ielisa
compar
favour
previous
report
accelisa
kimman
et
al
b
agre
previou
studi
found
superior
test
seroconvers
serodiagnosi
brsv
infect
field
sera
graham
et
al
result
demonstr
necess
control
nonspecif
igm
respons
benefit
amplifi
specif
respons
remov
compet
igg
effect
novel
method
pretreat
sera
indic
regard
recommend
protocol
deplet
serum
igg
routin
incorpor
protocol
ielisa
measur
specif
igm
order
elimin
dual
possibl
fals
posit
result
due
igmrf
fals
neg
result
due
interisotyp
competit
